Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 10. Отображено 10.
09-06-2015 дата публикации

COMPOSITION INCLUDING PROTOCATECHUIC ALDEHYDE AS ACTIVE INGREDIENT FOR TREATING OR PREVENTING VASCULAR DISORDERS

Номер: KR1020150063229A
Принадлежит:

The present invention relates to a composition including protocatechuic aldehyde (PCA) as an active ingredient for treating or preventing vascular disorders. The PCA which is an active ingredient in the present invention has effects in controlling vascular endothelial cell inflammation, protecting vascular endothelial cells, and inhibiting neointimal proliferation to be very effectively used in preventing or treating various vascular disorders caused by damage to vascular endothelial cells. On the other hand, the PCA is harmless to the human body as a natural material and rarely exhibits toxicity and side effects, to be safely used even when being used for a long time and stably applied to a pharmaceutical or food composition. COPYRIGHT KIPO 2015 ...

Подробнее
07-10-2015 дата публикации

Compositions for Prevention or Treating Autoimmune Thyroid Diseases

Номер: KR0101558477B1
Автор: 이은직, 구철룡
Принадлежит: 연세대학교 산학협력단

... 본 발명은 바이구아니드(biguanide) 유도체, 보다 구체적으로는 메트포민(metformin)을 유효성분으로 포함하는 자가면역성 갑상선 질환(Autoimmune Thyroid Diseases)의 예방 또는 치료용 약제학적 조성물에 관한 것이다. 본 발명의 조성물은 낮은 세포 독성을 가지면서도 히알루로난(Hyaluronan)의 생성 및 지방의 분화를 유의하게 억제함으로써 갑상선 자가항체에 의해 발생하는 다양한 병리적 상태, 예를 들어 갑상선 안구병증을 효과적으로 치료 또는 개선할 수 있다.

Подробнее
03-11-2015 дата публикации

Compositions for Prevention or Treating Autoimmune Thyroid Diseases

Номер: KR0101565029B1

... 본 발명은 연방(nelumbo nucifera Gaerth) 추출물을 유효성분으로 포함하는 자가면역성 갑상선 질환(Autoimmune Thyroid Diseases)의 예방 또는 치료용 약제학적 조성물 또는 자가면역성 갑상선 질환의 완화 또는 개선용 식품조성물에 관한 것이다. 본 발명의 조성물은 히알루로난(Hyaluronan)의 생성, 지방의 분화 및 염증반응을 유의하게 억제함으로써 갑상선 자가항체에 의해 발생하는 다양한 병리적 상태, 예를 들어 갑상선 안구병증을 효과적으로 치료 또는 개선할 수 있다.

Подробнее
07-11-2019 дата публикации

COMPOSITION FOR EXCRETION OF SUGAR

Номер: WO2019212279A1
Принадлежит:

The present invention provides a composition for excretion of sugar in which an epidermal growth factor receptor (EGFR) ligand is primarily coated with any one of collagen, wheat protein, soybean protein, skim milk, and whey, whereby the ligand passes through the stomach to promote the excretion of sugars during defecation.

Подробнее
16-07-2020 дата публикации

COMPOSITION FOR TARGETING MEDULLARY THYROID CANCER

Номер: WO2020145776A1
Принадлежит:

The present invention relates to a composition for targeting medullary thyroid cancer, the composition comprising a diagnostic radionucleotide-labeled ligand of the olfactory receptor OR51E2. The composition is internalized into parafollicular C cells by the olfactory receptor OR51E2 that is expressed on the parafollicular C cells of the thyroid gland and as such, can be advantageously used for diagnosing parafollicular C cell-derived medullary thyroid cancer and identifying whether or not parafollicular C cell-derived medullary thyroid cancer metastases. In addition, a pharmaceutical composition comprising an acetate-associated therapeutic radionucleotide for treatment of medullary thyroid cancer can be used for treatment of medullary thyroid cancer because the composition is internalized into cancer cells through the binding of the acetate to the olfactory receptor OR51E2.

Подробнее
16-05-2019 дата публикации

ENZYME COMPOSITION FOR REGULATING SUGAR METABOLISM

Номер: WO2019093663A1
Принадлежит:

The present invention relates to an enzyme composition for regulating sugar metabolism, and particularly, to an enzyme composition for regulating sugar metabolism, wherein the enzyme composition includes: at least one type of enzyme selected from the group consisting of glucoamylase, sucrase, and lactase; glucose oxidase; and transglucosidase. The enzyme composition for regulating sugar metabolism can regulate the absorption of glucose into the body by converting the carbohydrates in food to a form of sugar that is not absorbed in the stomach and the like before being decomposed in the small intestine into glucose by the activity of various enzymes such as maltase, sucrase, or lactase and the like and absorbed. Accordingly, the enzyme composition is expected to be extremely useful for people who due to obesity need to regulate carbohydrate consumption or people who are at risk of hyperglycemia or diabetes and thus need to regulate blood sugar.

Подробнее
02-04-2015 дата публикации

COMPOSITION FOR PREVENTING OR TREATING AUTOIMMUNE THYROID DISEASES

Номер: WO2015046857A1
Принадлежит:

The present invention relates to a pharmaceutical composition for preventing or treating autoimmune thyroid diseases, comprising a biguanide derivative and, more specifically, metformin as an active ingredient. The composition of the present invention can effectively treat or improve various pathologic conditions caused by thyroid autoantibody, for example thyroid-associated ophthalmopathy, by significantly inhibiting hyaluronan production and adipocyte differentiation while having a low cytotoxicity.

Подробнее
23-04-2020 дата публикации

COMPOSITION FOR DIAGNOSING HYPERPROLACTINEMIA, AND METHOD FOR PROVIDING INFORMATION FOR PREDICTING RESPONSE TO DRUG TREATMENT

Номер: WO2020080739A1
Принадлежит:

The present invention relates to a composition for diagnosing hyperprolactinemia, and methods for providing diagnosis-related information and information for predicting response to a drug treatment. Not only can hyperprolactinemia be diagnosed, but hyperprolactinemia that is caused by prolactinoma can be identified, thus allowing a highly effective treatment method to be provided for hyperprolactinemia that is low in adverse effects and high in probability of a full recovery.

Подробнее
23-12-2015 дата публикации

GENE RELATED TO PITUITARY TUMOR AND USE THEREOF

Номер: KR1020150142881A
Принадлежит:

The present invention relates to a kit for diagnosing diseases caused by hypersecretion of growth hormone, and a screening method of substances for preventing or treating diseases caused by hypersecretion of growth hormone. The present invention can be helpfully used in early and reliably diagnosing diseases caused by hypersecretion of growth hormone such as growth hormone secretory pituitary tumors and hyperpituitarism or predicting risk of the diseases by using a gene or a protein marker. COPYRIGHT KIPO 2016 ...

Подробнее
02-11-2015 дата публикации

ANIMAL MODEL FOR PITUITARY ADENOMA

Номер: KR1020150122373A
Принадлежит:

The present invention relates to a gene carrier for producing growth hormone hypersecretion disease-induced animals, a method for producing growth hormone hypersecretion disease-induced animals using the same and growth hormone hypersecretion disease-induced animals produced thereby. The present invention provides Aip genes which control cell growth, proliferation and a fission process to growth stimulated cells specific deleted animal models, and thus growth hormone hypersecretion diseases and, especially, a growth hormone secretory pituitary tumor specific animal model can be efficiently produced. The present invention can be used as a valuable research tool in the growth hormone hypersecretion disease study such as the growth hormone secretory pituitary tumor and hyperpituitarism. COPYRIGHT KIPO 2016 ...

Подробнее